Noticias de dinero

Time to end the 340B? – Health Economist

A Health Issues article Di Giorgio (2023) claims that the 340B has outlived itself. He wrote: By requiring pharmaceutical companies to provide a large discount to covered entities, most of which are hospitals with a disproportionate share or critical access, program 340V was intended to provide a financial buffer for

READ MORE
Noticias de dinero

Economist optimistic about FDI recovery

Economist AN is optimistic about the recovery of foreign direct investment (FDI) in the Philippines, given the ongoing recovery of the domestic economy. Bangko Sentral ng Pilipinas (BSP) reported on Friday a 23.2% decline in net FDI inflows to $9.2 billion in 2022 compared to the previous year and a 76.2% drop in net inflows

READ MORE
Noticias de dinero

Health Implications of COVID – Health Economist

An interesting article from Zidane, Simon and Wing (2023): The decline in healthcare consumption early in the pandemic provides insight into the underlying economic issues of waste and productivity in the US healthcare system. Using linked mortality and electronic health records, we compare people who had scheduled outpatient appointments for

READ MORE
Noticias de dinero

What is Tukey’s outlier? – Health Economist

Previously, CMS used Tukey’s outlier removal method to calculate Medicare Advantage (MA) and Medicare Part D prescription drug plans (PDP) star ratings. However, the final rule introduced in 2022 removed Tukey’s use of removing outliers from quality scores. Based on historical data for 2020 17% of MA plans will have a lower star rating compared

READ MORE